OBIS Press Releases - EIN Presswire - Press Release Distribution Service

Published on September 12, 2024 - 10:00 GMT

Gearing up for European Society for Medical Oncology (ESMO24) Congress with OBiS Insights Free Pre-Meeting Report

OBiS Insights pre-meeting ESMO24 report is based on a review of the 2,960 abstract titles of which 275 new not yet approved drugs have been profiled. NEW YORK, NY, UNITED STATES, September 12, 2024 /⁨EINPresswire.com⁩/ -- OBiS, a New York City-based …

Distribution channels: Banking, Finance & Investment Industry, Conferences & Trade Fairs ...

Published on September 12, 2024 - 07:50 GMT

Préparation au Congrès Oncologie ESMO24 avec le Rapport Gratuit d’OBiS Insights

Le rapport pré-réunion ESMO24 d'OBiS Insights est basé sur l'examen de 2 960 titres de résumés, avec 275 nouveaux médicaments non encore approuvés profilés. OLORON-SAINTE-MARIE, PYRéNéES-ATLANTIQUE, FRANCE, September 12, 2024 /⁨EINPresswire.com⁩/ …

Distribution channels: Conferences & Trade Fairs, Education ...

Published on September 12, 2024 - 02:00 GMT

OBiS Insights免費會前報告：迎接歐洲醫學腫瘤學會（ESMO24）大會

OBiS Insights 會前ESMO24報告基於對2,960個摘要標題的審查，以對尚未批准的新癌症藥物進行分類。 NEW YORK, NY, UNITED STATES, September 12, 2024 /⁨EINPresswire.com⁩/ -- 總部位於紐約市的醫療分析顧問公司OBiS，基於即將舉行的歐洲醫學腫瘤學會（ESMO）大會的摘要標題，開發了一份會前報告。該報告基於2,960篇摘要標題的審查，其中對275種尚未獲批的新藥進行了分類介紹。以下鏈接可免費下載報告： OBiS …

Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...

Published on September 12, 2024 - 02:00 GMT

Gearing up for the European Society for Medical Oncology (ESMO24) Congress with OBiS Insights Free Pre-Meeting Report

OBiS Insights pre-meeting ESMO24 report is based on a review of the 2,960 abstract titles of which 275 new not yet approved drugs have been profiled. NEW YORK, NY, UNITED STATES, September 12, 2024 /⁨EINPresswire.com⁩/ -- OBiS, a New York City-based …

Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...

Published on September 12, 2024 - 01:00 GMT

유럽종양학회(ESMO24) 학술대회를 준비하며 OBiS Insights 무료 사전 보고서 발표

OBiS Insights 사전 회의 ESMO24 보고서는 아직 승인되지 않은 새로운 암 약물을 분류하기 위해 2,960개의 초록 제목에 대한 검토를 기반으로 합니다. NEW YORK, NY, UNITED STATES, September 12, 2024 /⁨EINPresswire.com⁩/ -- 뉴욕시에 본사를 둔 의료 분석 컨설팅 회사인 OBiS는 다가오는 유럽종양학회(ESMO) 학술대회를 앞두고 사전 보고서를 개발했습니다. 이 보고서는 2,960개의 …

Distribution channels: Conferences & Trade Fairs, Education ...

Published on September 12, 2024 - 01:00 GMT

欧州臨床腫瘍学会（ESMO24）に向けたOBiS Insights無料プレミーティングレポート発表

OBiS InsightsのESMO24会議前レポートは、2,960のアブストラクトタイトルのレビューに基づいており、そのうち275のまだ承認されていない新薬がプロファイリングされています。 NEW YORK, NY, UNITED STATES, September 12, 2024 /⁨EINPresswire.com⁩/ -- ニューヨーク市を拠点とする医療分析コンサルティング会社であるOBiSは、欧州臨床腫瘍学会（ESMO）に先立つ、プレミーティングレポートを作成しました。本レポートは、ESMO …

Distribution channels: Chemical Industry, Conferences & Trade Fairs ...

Published on September 11, 2024 - 22:00 GMT

Gearing up for European Society for Medical Oncology (ESMO24) Congress with OBiS Insights Free Pre-Meeting Report

OBiS Insights pre-meeting ESMO24 report is based on a review of the 2,960 abstract titles of which 275 new not yet approved drugs have been profiled. NEW YORK, NY, UNITED STATES, September 12, 2024 /⁨EINPresswire.com⁩/ -- OBiS, a New York City-based …

Distribution channels: Banking, Finance & Investment Industry, Conferences & Trade Fairs ...

Published on May 22, 2024 - 17:24 GMT

New Antibody Drug Conjugates (ADCs) presented at the AACR 2024 Annual Meeting

Antibody Drug Conjugates (ADCs) were one of the most popular drug modalities presented at the AACR annual meeting last month. NEW YORK, NEW YORK, UNITED STATES, May 22, 2024 /⁨EINPresswire.com⁩/ -- Another exciting American Association for Cancer Research …

Distribution channels: Business & Economy, Companies ...

Published on July 10, 2023 - 11:37 GMT

Résumé des anticorps conjugués présentés lors de la réunion annuelle de 2023 de l'American Society of Clinical Oncology

Les anticorps conjugués (ADC) étaient l'une des classes de médicaments les plus populaires présentées lors de la réunion annuelle de l'ASCO plus tôt ce mois-ci. OLORON-SAINTE-MARIE, PYRéNéES-ATLANTIQUES, FRANCE, July 10, 2023 /⁨EINPresswire.com⁩/ …

Distribution channels: Business & Economy, Chemical Industry ...

Published on June 27, 2023 - 12:30 GMT

Summary of Antibody Drug Conjugates (ADCs) Presented at the American Society of Clinical Oncology 2023 Annual Meeting

Antibody Drug Conjugates (ADCs) were one of the most popular drug classes presented at the ASCO annual meeting earlier this month. NEW YORK, NEW YORK, UNITED STATES, June 27, 2023 /⁨EINPresswire.com⁩/ -- One of the largest classes of emerging cancer …

Distribution channels: Business & Economy, Chemical Industry ...

Published on June 23, 2023 - 13:12 GMT

The ADCs of ASCO 2023

Antibody Drug Conjugates (ADCs) were one of the most popular drug classes presented at the ASCO annual meeting earlier this month. NEW YORK, NEW YORK, UNITED STATES, June 23, 2023 /⁨EINPresswire.com⁩/ -- One of the largest classes of emerging cancer …

Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...